|
Year
|
Title
|
Authors
|
Publication
|
|
2019
|
Learning the dynamic treatment regimes from medical registry data through deep Q-network.
|
Liu N, Liu Y, Logan B, Xu Z, Tang J, Wang Y
|
Sci Rep 9(1):1495
|
|
2019
|
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL.
|
Dreger P, Sureda A, Ahn KW, Eapen M, Litovich C, Finel H, Boumendil A, Gopal A, Herrera AF, Schmid C, Diez-Martin JL, Fuchs E, Bolaños-Meade, Gooptu M, Al Malki MM, Castagna L, Ciurea S, Dominietto A, Blaise D, Ciceri F, Tischer J, Corradini P, Montoto S, Robinson S, Gülbas Z, Hamadani M
|
Blood Advances
|
|
2019
|
The concentration of total nucleated cells in harvested bone marrow for transplantation has decreased over time.
|
Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson CN, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, Ganguly S, Gastineau DA, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Norkin M, Olsson RF, Papari M, Savani BN, Szer J, Waller EK, Wirk B, Yared JA, Pulsipher MA, Shah NN, Switzer GE, O'Donnell PV, Confer DL, Shaw BE
|
Biol Blood Marrow Transplant
|
|
2019
|
Peripheral blood versus bone marrow from unrelated donors: Bone marrow allografts have improved long-term overall and graft-versus-host disease-free, relapse-free survival.
|
Alousi A, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Pidala J, Anderlini P, Boyiadzis M, Bredeson CN, Cahn J-Y, Cairo MS, Gadalla SM, Hashmi SK, Gale RP, Kanda J, Kamble RT, Kharfan-Dabaja MA, Litzow MR, Ringden O, Saad AA, Schultz KR, Verdonck LF, Waller EK, Yared JA, Holtan SG, Weisdorf DJ
|
Biol Blood Marrow Transplant 25(2):270-278
|
|
2019
|
Outcomes of haploidentical transplantation in patients with relapsed multiple myeloma: An EBMT/CIBMTR report.
|
Sahebi F, Garderet L, Kanate AS, Eikema DJ, Knelange NS, Alvelo OFD, Koc Y, Blaise D, Bashir Q, Moraleda JM, Dreger P, Sanchez JF, Ciurea S, Schouten H, Shah NN, Verbeek M, Rösler W, Diez-Martin JL, Schoenland S, D'Souza A, Kröger N, Hari P
|
Biol Blood Marrow Transplant 25(2):335-342
|
|
2019
|
Characteristics of late fatal infections after allogeneic hematopoietic cell transplantation.
|
Norkin M, Shaw BE, Brazauskas R, Tecca HR, Leather HL, Gea-Banacloche J, Kamble RT, DeFilipp Z, Jacobsohn DA, Ringden O, Inamoto Y, Kasow KA, Buchbinder D, Shaw P, Hematti P, Schears R, Badawy SM, Lazarus HM, Bhatt N, Horn B, Chhabra S, Page KM, Hamilton B, Hildebrandt GC, Yared JA, Agrawal V, Beitinjaneh AM, Majhail N, Kindwall-Keller T, Olsson RF, Schoemans H, Gale RP, Ganguly S, Ahmed IA, Schouten HC, Liesveld JL, Khera N, Steinberg A, Shah AJ, Solh M, Marks DI, Rybka W, Aljurf M, Dietz AC, Gergis U, George B, Seo S, Flowers MED, Battiwalla M, Savani BN, Riches ML, Wingard JR
|
Biol Blood Marrow Transplant 25(2):362-368
|
|
2019
|
Neoantigenic potential of complex chromosomal rearrangements in mesothelioma.
|
Mansfield AS, Peikert T, Smadbeck JB, Udell JBM, Garcia-Rivera E, Elsbernd L, Erskine CL, Van Keulen VP, Kosari F, Murphy SJ, Ren H, Serla VV, Schaefer Klein JL, Karagouga G, Harris FR, Sosa C, Johnson SH, Nevala W, Markovic SN, Bungum AO, Edell ES, Dong H, Cheville JC, Aubry MC, Jen J, Vasmatzis G
|
J Thorac Oncol 14(2):276-287
|
|
2019
|
Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
|
Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Stanghellini MTL, Argrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rovó A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers ME, Shaw BE, Petriček I
|
Biol Blood Marrow Transplant 25(2):e46-e54
|
|
2019
|
Outcomes after second hematopoietic cell transplantation in children and young adults with relapsed acute leukemia.
|
Lund TC, Ahn KW, Tecca HR, Hilgers MV, Abdel-Azim H, Abraham A, Diaz MA, Badawy SM, Broglie L, Brown V, Dvorak CC, Gonzalez-Vicent M, Hashem H, Hayashi RJ, Jacobsohn DA, Kent MW, Li C-K, Margossian SP, Martin PL, Mehta P, Myers K, Olsson R, Page K, Pulsipher MA, Shaw PJ, Smith AR, Triplett BM, Verneris MR, Eapen M
|
Biol Blood Marrow Transplant 25(2):301-306
|
|
2019
|
Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: A CIBMTR contemporary longitudinal study.
|
Abidi MZ, Hari P, Chen M, Kim S, Battiwala M, Dahi PB, Diaz MA, Gale RP, Ganguly S, Gergis U, Green J, Hildebrandt G, Hill JA, Komanduri K, Lazarus H, Marks D, Nishihori T, Olsson R, Seo S, Ustun C, Yared J, Yin D, Wingard J, Wirk BM, Auletta J, Lindemans C, Riches M
|
Bone Marrow Transplant
|
|
2019
|
Autologous transplantation, consolidation and maintenance therapy in multiple myeloma
|
Stadtmauer E, Pasquini M, Blackwell E, Parameswaran H, Bashey A, Devine S, Efebera Y, Ganguly S, Gasparetto C, Gasparetto C, Geller N, Horowitz M, Koreth J, Knust K, Landau H, Brunstein C, McCarthy P, Nelson C, Qazilbash M, Shah N, Vesole D, Vij R, Vogt D, Giralt S, Somlo G, Krishnan A
|
J Clin Oncol
|
|
2019
|
Graft versus host disease clinical trials: is it time for patients centered outcomes to be the primary objective?
|
Shaw BE
|
Curr Hematol Malig Rep
|
|
2019
|
Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study.
|
Papanicolau GA, Ustun C, Young JH, Chen M, Kim S, Ahn KW, Komanduri K, Lindemans CA, Auletta JJ, Riches ML
|
Clin Infect Dis
|
|
2019
|
Functional and radiologic assessment of the brain after reduced intensity unrelated donor transplantation for severe sickle cell disease BMT CTN 0601
|
King A, McKinstry R, Wu J, Eapen M, Abel R, Varughese, Taniya, Kamani N, Shenoy S
|
Biol Blood Marrow Transplant
|
|
2019
|
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: A CIBMTR analysis.
|
Epperla N, Ahn KW, Litovich C, Ahmed S, Battiwalla M, Cohen JB, Dahi P, Farhadfar N, Farooq U, Freytes CO, Ghosh N, Haverkos B, Herrera A, Hertzberg M, Hildebrandt G, Inwards D, Kharfan-Dabaja MA, Khimani F, Lazarus H, Lazaryan A, Lekakis L, Murthy H, Nathan S, Nishihori T, Pawarode A, Prestidge T, Ramakrishnan P, Rezvani AR, Romee R, Shah NN, Sureda A, Fenske TS, Hamadani M
|
J Hematol Oncol 12(1):6
|
|
2019
|
Nonparametric competing risks analysis using Bayesian Additive Regression Trees.
|
Sparapani R, Logan BR, McCulloch RE, Laud PW
|
Stat Methods Med Res
|
|
2019
|
KIR donor selection: Feasibility in identifying better donors.
|
Weisdorf D, Cooley S, Wang T, Trachtenberg E, Haagenson MD, Vierra-Green C, Spellman SR, Spahn A, Vogel J, Kobusingye H, Fehninger T, Woolfrey A, Devine S, Ross M, Waller EK, Sobecks R, Parham P, Guethlein LA, Marsh SGE, Miller J
|
Biol Blood Marrow Transplant 25(1):e28-e32
|
|
2019
|
Proinflammatory cytokine and adipokine levels in adult unrelated marrow donors are not associated with hematopoietic cell transplantation outcomes.
|
Turcotte LM, Wang T, Hemmer MT, Spellman SR, Arora M, Yingst A, Couriel D, Alousi A, Pidala J, Knight JM, Verneris MR
|
Biol Blood Marrow Transplant 25(1):12-18
|
|
2019
|
Rates and risk factors for post-traumatic stress disorder symptomatology among adult hematopoietic cell transplant recipients and their informal caregivers.
|
Liang J, Lee SJ, Storer BE, Shaw BE, Chow EJ, Flowers ME, Krakow EF, Bar M, Syrjala KL, Salit RB, Kurukulasuriya CE, Jim HSL
|
Biol Blood Marrow Transplant 25(1):145-150
|
|
2019
|
Comparative analysis of calcineurin inhibitor-based methotrexate and mycophenolate mofetil-containing regimens for prevention of graft-versus-host disease after reduced-intensity conditioning allogeneic transplantation.
|
Chhabra S, Liu Y, Hemmer MT, Costa L, Pidala JA, Couriel DR, Alousi AM, Majhail NS, Stuart RK, Kim D, Ringden O, Urbano-Ispizua A, Saad A, Savani BN, Cooper B, Marks DI, Socie G, Schouten HC, Schoemans H, Abdel-Azim H, Yared J, Cahn J-Y, Wagner J, Antin JH, Verdonck LF, Lehmann L, Aljurf MD, MacMillan ML, Litzow MR, Solh MM, Qayed M, Hematti P, Kamble RT, Vij R, Hayashi RJ, Gale RP, Martino R, Seo S, Hashmi SK, Nishihori T, Teshima T, Gergis U, Inamoto Y, Spellman SR, Arora M, Hamilton BK
|
Biol Blood Marrow Transplant 25(1):73-85
|
|
2019
|
Post‐transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR).
|
Bhatt NS, Brazauskas R, Tecca HR, Carreras J, Burns LJ, Phelan R, Salit RB, Syrjala KL, Talano JM, Shaw BE
|
Cancer 125(1):144-152
|
|
2019
|
The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018).
|
Dvorak CC, Haddad E, Buckley RH, Cowan MJ, Logan B, Griffith LM, Kohn DB, Pai S-Y, Notarangelo L, Shearer W, Prockop S, Kapoor N, Heimall J, Chaudhury S, Shyr D, Chandra S, Cuvelier G, Moore T, Shenoy S, Goldman F, Smith AR, Sunkersett G, Vander Lugt M, Caywood E, Quigg T, Torgerson T, Chandrakasan S, Craddock J, Dávila Saldaña BJ, Gillio A, Shereck E, Aquino V, DeSantes K, Knutsen A, Thakar M, Yu L, Puck JM
|
J Allergy Clin Immunol 143(1):405-407
|
